Rhenman & Partners Asset Management AB - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$3,234,000
-40.2%
80,000
-14.9%
0.52%
-20.6%
Q2 2015$5,410,000
-16.7%
94,000
-7.8%
0.65%
-40.6%
Q1 2015$6,494,000
+150.4%
102,000
+142.9%
1.10%
+45.6%
Q4 2014$2,593,000
+15.1%
42,000
-27.6%
0.75%
+14.1%
Q3 2014$2,252,000
+81.6%
58,000
+61.1%
0.66%
+79.1%
Q2 2014$1,240,00036,0000.37%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders